Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(48)
•••
Comment by langostaon May 05, 2018 1:32pm
117 Views
Post# 27987324

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinically cancer free ! ! ! :)

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinically cancer free ! ! ! :)
LaserStock29 wrote: We're just along for the ride as retail folk. I'll take $3 on any Monday morning from now till before ph2b.. Patient 6 should be 90day already And with any luck those identified patients 789 are being enrolled and treated. May is bladder cancer month Precommercial Pre Phase 2 value is $2-3 as I've shown a zillion times. So I'd welcome this.
jojomarch wrote: If RW agrees and votes his shares for a $3.00 takeover at this point  it's , IMO , because the fix is in .
The biotechs with integrity and results like TLT has achieved so far  do a JV  in the form of a licensing deal with milestone payments .

GO TLT GO

GO AM GO 

GO JV GO

HAPPY SATURDAY




Cancer Awareness Calendar

January

February

March

April

May

June

July

September

October

November

 

Cancer Awareness Calendar

January

February

March

April

May

June

July

September

October

November

*Used with permission

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities